CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Highlight Therapeutics

For profitWebsite ↗

Also known as: Highlight Therapeutics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

May 27, 2024

Timeline

2010s

Jun 1, 2010
Highlight Therapeutics— Founded

Drugs by trial phase (4 distinct, 6 trials)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

poly-iclc

Indications

Studied for

Colorectal Neoplasms

Recent trials (8)

NCT06422936Lead sponsorPhase 2May 27, 2024
NCT05265650CollaboratorPhase 1/Phase 2Jun 13, 2022
NCT04777708CollaboratorEarly Phase 1Oct 13, 2021
NCT04570332Lead sponsorPhase 2Dec 14, 2020
NCT04570332Study directorPhase 2Dec 14, 2020
NCT04420975CollaboratorPhase 1Jun 30, 2020
NCT04508140Lead sponsorPhase 2Jun 17, 2020
NCT04508140Study directorPhase 2Jun 17, 2020

Details

Founded: Paterna, ES Jun 1, 2010
Last known activity: May 27, 2024